Waltham, Massachusetts, United States Matrix Capital Management is the famous VC, which was founded in 1999. The main office of represented VC is situated in the Waltham. The company was established in North America in United States.
This organization was formed by David Goel, Paul Ferri. Besides them, we counted 7 critical employees of this fund in our database.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Matrix Capital Management, startups are often financed by Valar Ventures, Viking Global Investors, Illumina Accelerator. The meaningful sponsors for the fund in investment in the same round are Matrix Partners, Valar Ventures, Worldview Technology Partners. In the next rounds fund is usually obtained by Valar Ventures, TechAccel LLC, TCV.
Among the most popular fund investment industries, there are SaaS, Artificial Intelligence. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight Adaptive Biotechnologies, Encoded Therapeutics, Inc., EpiBiome. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
Opposing the other organizations, this Matrix Capital Management works on 18 percentage points less the average amount of lead investments. Deals in the range of 50 - 100 millions dollars are the general things for fund. When the investment is from Matrix Capital Management the average startup value is 500 millions - 1 billion dollars. The high activity for fund was in 2016. The top amount of exits for fund were in 2019. Considering the real fund results, this VC is 2 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year.
Related Funds
| Fund Name | Location |
| A. Soriano Corporation | Makati, Manila, Philippines |
| Bank of Kochi | Japan, Kochi, Kochi Prefecture |
| Beijing Ruibang Kaiyuan Investment | Beijing, Beijing, China |
| Beijing Yansai Luyou Touzi Co., Ltd. | Beijing, China, Huairou |
| Business Instincts Group | Alberta, Calgary, Canada |
| CEED - Centre for Entrepreneurship Education and Development | Canada, Halifax, Nova Scotia |
| Elegant Themes | California, San Francisco, United States |
| Enron North America | - |
| Huamei International | China, Guangdong, Guangzhou |
| Hyppo Corporation | - |
| JP Asia Prime Capital | Central, Central Region, Singapore |
| MG Holdings | China, Guangdong, Shenzhen |
| Mitsubishi Electric Affiliate | - |
| Ritchie Capital Management | Cayman Islands, Grand Cayman |
| Samsung Electronics | Seoul, Seoul-t'ukpyolsi, South Korea |
| Tamar Ventures | Herzliya, Israel, Tel Aviv |
| TEV | Tengelmann Ventures | Essen, Germany, Nordrhein-Westfalen |
| Var Business Angels | France, Provence-Alpes-Cote d'Azur, Toulon |
| Visa Ventures | California, San Francisco, United States |
Discover 5 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Rivos | $250M | 16 Apr 2024 | Mountain View, California, United States | ||
Esker Therapeutics | $259M | 06 Mar 2024 | - | ||
ReCode Therapeutics | $50M | 19 Sep 2023 | Dallas, Texas, United States | ||
AltPep | $52M | 22 Jun 2023 | Washington, United States | ||
ACELYRIN | $300M | 13 Sep 2022 | Los Angeles, California, United States | ||
Monod Bio | $25M | 15 Aug 2022 | Seattle, Washington, United States | ||
ReCode Therapeutics | $120M | 29 Jun 2022 | Dallas, Texas, United States | ||
Talos Trading | $105M | 10 May 2022 | New York, New York, United States | ||
Koneksa Health | $45M | 07 Feb 2022 | New York, New York, United States |
– Blockdaemon closed a Series B funding round of USD $155m with a valuation of $1.255b, making it the world’s largest blockchain infrastructure company for node management and staking.
– The round was led by SoftBank Vision Fund 2, with participation from Matrix Capital Management, Sapphire Ventures, and Morgan Creek Digital.
– This follows the company’s Series A Round in June 2021 of $28m, as well as previous strategic investments, bringing the total to just under $190m.
– Over the last 90 days, Blockdaemon has significantly accelerated its growth and increased its managed node count from 8,000 to 18,000, more than doubling its operational footprint.
– GentiBio, Inc. from Boston develops engineered regulatory T cells (Tregs) therapies for immunology.
– Series A $157m round was led by Matrix Capital Management with participation from Avidity Partners, JDRF T1D Fund, OrbiMed, RA Capital Management, and Novartis Venture Fund.
– The company intends to use the funds to advance its potential functional cure for Type 1 Diabetes (T1D) to the clinic alongside multiple other pipeline programs in chronic autoimmunity and autoinflammation.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Rivos | $250M | 16 Apr 2024 | Mountain View, California, United States | ||
Esker Therapeutics | $259M | 06 Mar 2024 | - | ||
ReCode Therapeutics | $50M | 19 Sep 2023 | Dallas, Texas, United States | ||
AltPep | $52M | 22 Jun 2023 | Washington, United States | ||
ACELYRIN | $300M | 13 Sep 2022 | Los Angeles, California, United States | ||
Monod Bio | $25M | 15 Aug 2022 | Seattle, Washington, United States | ||
ReCode Therapeutics | $120M | 29 Jun 2022 | Dallas, Texas, United States | ||
Talos Trading | $105M | 10 May 2022 | New York, New York, United States | ||
Koneksa Health | $45M | 07 Feb 2022 | New York, New York, United States |
